ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
Odds&Evens
|
478 |
205K |
22 |
13:00 |
13:00 |
ASX - By Stock
|
478
|
205K
|
22
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Odds&Evens
|
37K |
16M |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
37K
|
16M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar
|
|
Odds&Evens
|
51 |
15K |
11 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
51
|
15K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar
|
|
Odds&Evens
|
51 |
15K |
20 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
51
|
15K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar
|
|
Odds&Evens
|
51 |
15K |
23 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
51
|
15K
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Odds&Evens
|
144 |
58K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
58K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Odds&Evens
|
144 |
58K |
18 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
58K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Odds&Evens
|
144 |
58K |
16 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
58K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Odds&Evens
|
144 |
58K |
60 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
58K
|
60
|
|
ASX - By Stock
|
TBN |
Re:
Flare 1/28
|
|
Odds&Evens
|
62 |
24K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
62
|
24K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
Odds&Evens
|
163 |
58K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
58K
|
5
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Appointment of new Chief Financial Officer
|
|
Odds&Evens
|
6 |
1.5K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
6
|
1.5K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
11 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
303
|
115K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
18 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
303
|
115K
|
18
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Finniss Mineral Resource Increased by 58%
|
|
Odds&Evens
|
122 |
47K |
3 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
122
|
47K
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Finniss Mineral Resource Increased by 58%
|
|
Odds&Evens
|
122 |
47K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
122
|
47K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Odds&Evens
|
22K |
11M |
47 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
22K
|
11M
|
47
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Appointment of new Chief Financial Officer
|
|
Odds&Evens
|
6 |
1.5K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
6
|
1.5K
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Finniss Mineral Resource Increased by 58%
|
|
Odds&Evens
|
122 |
47K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
122
|
47K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Finniss Mineral Resource Increased by 58%
|
|
Odds&Evens
|
122 |
47K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
122
|
47K
|
4
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Finniss Mineral Resource Increased by 58%
|
|
Odds&Evens
|
122 |
47K |
16 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
122
|
47K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Odds&Evens
|
13K |
6.2M |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
13K
|
6.2M
|
2
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Appointment of new Chief Financial Officer
|
|
Odds&Evens
|
6 |
1.5K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
6
|
1.5K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Odds&Evens
|
13K |
6.2M |
38 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
13K
|
6.2M
|
38
|
|
ASX - By Stock
|
ORG Energy |
Re:
Banter and general comments
|
|
Odds&Evens
|
14 |
3.3K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
14
|
3.3K
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Odds&Evens
|
37K |
16M |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
37K
|
16M
|
0
|
|
ASX - By Stock
|
ORG Energy |
Re:
Banter and general comments
|
|
Odds&Evens
|
14 |
3.3K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
14
|
3.3K
|
0
|
|
ASX - By Stock
|
ORG Energy |
Re:
Banter and general comments
|
|
Odds&Evens
|
14 |
3.3K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
14
|
3.3K
|
1
|
|
ASX - By Stock
|
ORG Energy |
Banter and general comments
|
|
Odds&Evens
|
14 |
3.3K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
14
|
3.3K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
28 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
16 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
45 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
45
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
10 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
13 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
18 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
57 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
57
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
Odds&Evens
|
303 |
115K |
30 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
115K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Odds&Evens
|
22K |
11M |
13 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
22K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Odds&Evens
|
22K |
11M |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
22K
|
11M
|
4
|
|
ASX - By Stock
|
TBN |
Re:
General Chatter
|
|
Odds&Evens
|
163 |
70K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
163
|
70K
|
0
|
|
ASX - By Stock
|
AQX |
Re:
Ann: Trading Halt
|
|
Odds&Evens
|
15 |
3.6K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
15
|
3.6K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
Odds&Evens
|
118 |
54K |
20 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
54K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
Odds&Evens
|
118 |
54K |
30 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
54K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
11 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
10 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
14 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
Odds&Evens
|
127 |
54K |
30 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
127
|
54K
|
30
|
|